Learning Objectives

1. Describe the differential diagnosis for a neonatal acute life-threatening event

2. Explain causes of neonatal muscle weakness

3. Describe the clinical triad of type F infant botulism

4. Identify key epidemiological features of infant botulism and type F infant botulism

5. Explain the standard-of-care treatment for infant botulism, its method of action and recent efficacy outcomes, as well as the treatment of type F infant botulism



Click here to complete today’s evaluation: https://ce.icep.wisc.edu/neurology-grand-rounds-20-22-eval-15135

Session date: 
10/26/2020 - 4:00pm to 5:00pm CDT
Medical Foundation Centennial Bldg, Room #1220
1685 Highland Ave
Madison, WI 53705
United States
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.
Discloser List CME Internal Report